Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (246)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Elsubrutinib	BTK Inhibitor	Hematologic (Lymphoma/CLL)
Molecule Elsubrutinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma/CLL) Drug Class / Mechanism BTK Inhibitor
Idelalisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Idelalisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Copanlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Copanlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Duvelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Duvelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Alpelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Alpelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Umbralisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Umbralisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Taselisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Taselisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Inavolisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Inavolisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Gedatolisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Gedatolisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Serabelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Serabelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Pictilisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Pictilisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Buparlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Buparlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

Elsubrutinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma/CLL) Drug Class / Mechanism BTK Inhibitor
Idelalisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Copanlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Duvelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Alpelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Umbralisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Taselisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Inavolisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Gedatolisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Serabelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Pictilisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Buparlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

‹ 1 … 8 9 10 11 12 … 21 ›

Product Range

Company

Global Network

Products

Elsubrutinib

Idelalisib

Copanlisib

Duvelisib

Alpelisib

Umbralisib

Taselisib

Inavolisib

Gedatolisib

Serabelisib

Pictilisib

Buparlisib